Yaakov Maor

Summary

Country: Israel

Publications

  1. doi request reprint Genetic polymorphism of IL28B in hepatitis C-infected haemophilia patients in Israel
    Y Maor
    Department of Gastroenterology and Hepatology, Sheba Medical Centre, Tel Hashomer, Israel
    Haemophilia 19:150-6. 2013
  2. doi request reprint Treatment of hepatitis C in patients with haemophilia - the Israeli National Hemophilia Center experience
    Y Maor
    Department of Gastroenterology and Hepatology, Sheba Medical Center Tel Hashomer, Israel
    Haemophilia 14:336-42. 2008
  3. ncbi request reprint Non-invasive biomarkers of liver fibrosis in haemophilia patients with hepatitis C: can you avoid liver biopsy?
    Y Maor
    Department of Gastroenterology and Hepatology, Sheba Medical Center, Tel Hashomer, Israel
    Haemophilia 12:372-9. 2006
  4. ncbi request reprint The use of albumin in patients with decompensated cirrhosis: the case in favor
    Yaakov Maor
    Department of Gastroenterology and Hepatology, Sheba Medical Center, Tel Hashomer, Israel
    Isr Med Assoc J 7:115-8. 2005
  5. ncbi request reprint Hepatitis C at the israeli national hemophilia center
    Y Maor
    Department of Gastroenteroloy and Hepatology, Sheba Medical Center, Tel Hashomer, Israel
    Haemophilia 12:68-74. 2006
  6. doi request reprint Fibrotest or Fibroscan for evaluation of liver fibrosis in haemophilia patients infected with hepatitis C
    Y Maor
    Department of Gastroenterology and Hepatology, Sheba Medical Center, Tel Hashomer, Israel
    Haemophilia 16:148-54. 2010
  7. doi request reprint Long-term clinical outcome of patients with gastric gastrointestinal stromal tumors
    Yaakov Maor
    Department of Gastroenterology and Hepatology, Sheba Medical Center, Tel Hashomer, Israel
    Dig Dis Sci 55:2893-8. 2010
  8. ncbi request reprint Improving estimation of liver fibrosis using combination and newer noninvasive biomarker scoring systems in hepatitis C-infected haemophilia patients
    Y Maor
    Department of Gastroenterology and Hepatology, Sheba Medical Center, Tel Hashomer, Israel
    Haemophilia 13:722-9. 2007
  9. ncbi request reprint Endoscopic ultrasound staging of rectal cancer: diagnostic value before and following chemoradiation
    Yaakov Maor
    Department of Gastroenterology, Sheba Medical Center, Tel Hashomer, Israel
    J Gastroenterol Hepatol 21:454-8. 2006
  10. doi request reprint Lower doses of rFVIIa therapy are safe and effective for surgical interventions in patients with severe FXI deficiency and inhibitors
    G Kenet
    Thrombosis Unit, The Israeli National Hemophilia Center, The Institute of Thrombosis and Hemophilia, Sheba Medical Center, Tel Hashomer, Israel
    Haemophilia 15:1065-73. 2009

Collaborators

Detail Information

Publications24

  1. doi request reprint Genetic polymorphism of IL28B in hepatitis C-infected haemophilia patients in Israel
    Y Maor
    Department of Gastroenterology and Hepatology, Sheba Medical Centre, Tel Hashomer, Israel
    Haemophilia 19:150-6. 2013
    ..Likewise, patients who possess harbour the CC or TT genotypes were more likely to clear HCV infection spontaneously. A unique distribution of the CC genotype was observed in some ethnic groups...
  2. doi request reprint Treatment of hepatitis C in patients with haemophilia - the Israeli National Hemophilia Center experience
    Y Maor
    Department of Gastroenterology and Hepatology, Sheba Medical Center Tel Hashomer, Israel
    Haemophilia 14:336-42. 2008
    ..Anaemia was a major side effect and the use of growth factors seemed unrevealing...
  3. ncbi request reprint Non-invasive biomarkers of liver fibrosis in haemophilia patients with hepatitis C: can you avoid liver biopsy?
    Y Maor
    Department of Gastroenterology and Hepatology, Sheba Medical Center, Tel Hashomer, Israel
    Haemophilia 12:372-9. 2006
    ....
  4. ncbi request reprint The use of albumin in patients with decompensated cirrhosis: the case in favor
    Yaakov Maor
    Department of Gastroenterology and Hepatology, Sheba Medical Center, Tel Hashomer, Israel
    Isr Med Assoc J 7:115-8. 2005
    ..Albumin is relatively inexpensive and can be given in an outpatient setting...
  5. ncbi request reprint Hepatitis C at the israeli national hemophilia center
    Y Maor
    Department of Gastroenteroloy and Hepatology, Sheba Medical Center, Tel Hashomer, Israel
    Haemophilia 12:68-74. 2006
    ..3%; P = 0.045). The majority of haemophilia patients are infected with HCV. Viral clearance occurred in a minority of these patients. HCV monoinfected and HCV/HIV coinfected differ clinically and prognostically...
  6. doi request reprint Fibrotest or Fibroscan for evaluation of liver fibrosis in haemophilia patients infected with hepatitis C
    Y Maor
    Department of Gastroenterology and Hepatology, Sheba Medical Center, Tel Hashomer, Israel
    Haemophilia 16:148-54. 2010
    ..Nevertheless, the agreement between modalities was only fair and improved with more advanced stages of fibrosis. Practical algorithms for the accuracy of FT and FS may improve reliable evaluation of fibrosis in this population...
  7. doi request reprint Long-term clinical outcome of patients with gastric gastrointestinal stromal tumors
    Yaakov Maor
    Department of Gastroenterology and Hepatology, Sheba Medical Center, Tel Hashomer, Israel
    Dig Dis Sci 55:2893-8. 2010
    ..About 10-30% of gastrointestinal stromal tumors prove to be malignant. Nevertheless, the natural history of gastric gastrointestinal stromal tumors has not been fully elucidated...
  8. ncbi request reprint Improving estimation of liver fibrosis using combination and newer noninvasive biomarker scoring systems in hepatitis C-infected haemophilia patients
    Y Maor
    Department of Gastroenterology and Hepatology, Sheba Medical Center, Tel Hashomer, Israel
    Haemophilia 13:722-9. 2007
    ..The concordance rate between FT and FibroMeter is higher compared with the other biomarkers. Practical combination of tests may potentially limit the need of liver biopsy in the majority of haemophilia patients...
  9. ncbi request reprint Endoscopic ultrasound staging of rectal cancer: diagnostic value before and following chemoradiation
    Yaakov Maor
    Department of Gastroenterology, Sheba Medical Center, Tel Hashomer, Israel
    J Gastroenterol Hepatol 21:454-8. 2006
    ..Nevertheless, the accuracy of EUS after chemoradiation remains unclear; therefore the purpose of the present paper was to compare the accuracy of EUS staging for rectal cancer before and following chemoradiation...
  10. doi request reprint Lower doses of rFVIIa therapy are safe and effective for surgical interventions in patients with severe FXI deficiency and inhibitors
    G Kenet
    Thrombosis Unit, The Israeli National Hemophilia Center, The Institute of Thrombosis and Hemophilia, Sheba Medical Center, Tel Hashomer, Israel
    Haemophilia 15:1065-73. 2009
    ..Recombinant FVIIa at low doses may effectively induce haemostasis and seems to be a safe treatment mode in patients with FXI deficiency and inhibitors undergoing surgeries...
  11. ncbi request reprint Prophylaxis for travel-related thrombosis? No
    A Lubetsky
    National Hemophilia Center and Institute of Thrombosis and Hemostasis, Sheba Medical Center, Tel Hashomer and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
    J Thromb Haemost 2:2092-3. 2004
  12. ncbi request reprint Assessment of the coagulation profile in hemato-oncological patients receiving ATG-based conditioning treatment for allogeneic stem cell transplantation
    A Inbal
    Institute of Thrombosis and Hemostasis, Sheba Medical Center, Tel Hashomer, Israel
    Bone Marrow Transplant 34:459-63. 2004
    ..Our results suggest that allo-SCT is not associated with increased hypercoagulability and addition of ATG to conditioning regimen has no significant procoagulant effect...
  13. doi request reprint Stability, efficacy, and safety of continuously infused sucrose-formulated recombinant factor VIII (rFVIII-FS) during surgery in patients with severe haemophilia
    U Martinowitz
    The Israel National Hemophilia Center, Chaim Sheba Medical Center, Tel Hashomer, Israel
    Haemophilia 15:676-85. 2009
    ..There were no adverse events, including inhibitor formation, related to rFVIII-FS. rFVIII-FS was found to be suitable for use in CI in haemophilia A patients undergoing major surgery...
  14. doi request reprint Severe and morbid obesity in Crohn's disease patients: prevalence and disease associations
    Bella Ungar
    Departments of Internal Medicine D, Sheba Medical Center, Tel Hashomer and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
    Digestion 88:26-32. 2013
    ..Conclusion: CD in severely/morbidly obese patients is more often colonic, but otherwise no different than CD in nonobese patients. Sleeve gastrectomy is a viable therapeutic option for morbidly obese CD patients. ..
  15. doi request reprint Idiopathic liver function test abnormality in pregnancy is associated with assisted reproduction techniques
    Uri Kopylov
    Department of Gastroenterology and Hepatology, Sheba Medical Center, Tel Hashomer, Israel
    Fertil Steril 99:377-81. 2013
    ....
  16. ncbi request reprint Endosonographic evaluation of perianal fistulas and abscesses: comparison of two instruments and assessment of the role of hydrogen peroxide injection
    Yaakov Maor
    Department of Gastroenterology and Hepatology and Department of Surgery, Sheba Medical Center, Tel Hashomer, Israel
    J Clin Ultrasound 33:226-32. 2005
    ..The aims of this study were to compare the performance of a mechanical radial endosonoscope and an endorectal electronic probe and to evaluate the value of hydrogen peroxide (H(2)O(2)) injection in the diagnosis of perianal fistulas...
  17. ncbi request reprint Interindividual variability in sensitivity to warfarin--Nature or nurture?
    R Loebstein
    Division of Clinical Pharmacology and Toxicology and the Anticoagulation Clinic, Department of Medicine, The Chaim Sheba Medical Center, Tel Hashomer, Israel
    Clin Pharmacol Ther 70:159-64. 2001
    ....
  18. ncbi request reprint A new approach to treatment of bleeding episodes in young hemophilia patients: a single bolus megadose of recombinant activated factor VII (NovoSeven)
    G Kenet
    The Israeli National Hemophilia Center, Tel Hashomer, Israel
    J Thromb Haemost 1:450-5. 2003
    ..4 U mL(-1); range: 19.8-54 U mL(-1)). Treatment of bleeds with a rFVIIa megadose in young inhibitor patients is effective and well tolerated...
  19. doi request reprint Aspirin responsiveness in acute brain ischaemia: association with stroke severity and clinical outcome
    Y Schwammenthal
    Stroke Center, Department of Neurology, Sheba Medical Center, Tel Hashomer, Israel
    Cerebrovasc Dis 25:355-61. 2008
    ..Platelets play a critical role in the pathogenesis of acute brain ischaemia. We studied the association between the degree of inhibition of platelet function by aspirin (ASA) and the severity and outcome of acute brain ischaemia...
  20. ncbi request reprint Platelet function of newborns as tested by cone and plate(let) analyzer correlates with gestational Age
    Y Levy-Shraga
    Pediatric Department, The Edmond and Lily Safra Children s Hospital, Tel Hashomer, Israel
    Acta Haematol 115:152-6. 2006
    ..Conclusion: CPA provides a rapid, feasible option for testing platelet function in neonates. Its potential predictive value deserves further attention, and more extensive studies are warranted...
  21. ncbi request reprint The 1226G (N370S) Gaucher mutation among patients with Legg-Calve-Perthes disease
    G Kenet
    National Hemophilia Center and Institute of Thrombosis and Hemostasis, Sheba Medical Center, Tel Hashomer, Israel
    Blood Cells Mol Dis 31:72-4. 2003
    ..01). Since Gaucher disease may be misdiagnosed as LCPD, glucocerebrosidase enzyme testing is recommended among Ashkenazi Jewish children diagnosed with LCPD...
  22. ncbi request reprint Congenital anomalies of the inferior vena cava revealed on CT in patients with deep vein thrombosis
    G Gayer
    Department of Diagnostic Imaging, Sheba Medical Center, Tel Hashomer 52621, Israel
    AJR Am J Roentgenol 180:729-32. 2003
    ..Coagulation abnormalities, frequently found in these patients, may be a contributory factor...
  23. ncbi request reprint Efficacy and safety of a factor VIII-von Willebrand factor concentrate 8Y: stability, bacteriological safety, pharmacokinetic analysis and clinical experience
    A Lubetsky
    Institute of Thrombosis and Hemostasis, Sheba Medical Center, Tel Hashomer, Israel
    Haemophilia 8:622-8. 2002
    ..In two patients treated with 8Y by continuous infusion for prevention or treatment of bleeding haemostasis was achieved. Thus, 8Y is suitable and haemostatically effective for continuous infusion treatment in patients with vWD...
  24. ncbi request reprint Maternal selective serotonin reuptake inhibitor intake does not seem to affect neonatal platelet function tests
    A Maayan-Metzger
    Department of Neonatology, The Edmond and Lily Safra Children s Hospital, Tel Hashomer, Israel
    Acta Haematol 115:157-61. 2006
    ..None of the babies suffered from bleeding. We conclude that maternal SSRI therapy does not impair whole-blood CPA-tested platelet function of healthy full-term neonates...